{
    "Trade/Device Name(s)": [
        "AssureTech Panel Dip Tests",
        "AssureTech Quick Cup Tests"
    ],
    "Submitter Information": "Assure Tech. Co., Ltd.",
    "510(k) Number": "K180349",
    "Predicate Device Reference 510(k) Number(s)": [
        "K153050"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NFT",
        "NFW",
        "NFY",
        "NGG",
        "NGL",
        "NFV",
        "PTH",
        "NGM",
        "PTG",
        "QAW",
        "QBF"
    ],
    "Summary Letter Date": "April 5, 2018",
    "Summary Letter Received Date": "February 8, 2018",
    "Submission Date": "February 5, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3870",
        "21 CFR 862.3250",
        "21 CFR 862.3610",
        "21 CFR 862.3650",
        "21 CFR 862.3170",
        "21 CFR 862.3150",
        "21 CFR 862.3620",
        "21 CFR 862.3910",
        "21 CFR 862.3700"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system",
        "Cannabinoids test system",
        "Cocaine and cocaine metabolites test system",
        "Methamphetamine test system",
        "Morphine test system",
        "Benzodiazepine test system",
        "Opiate test system",
        "Barbiturate test system",
        "Methadone test system",
        "Tricyclic antidepressant drugs test system",
        "Propoxyphene test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Oxazepam",
        "Cocaine",
        "Marijuana",
        "Methamphetamine",
        "Morphine",
        "Oxycodone",
        "Secobarbital",
        "Buprenorphine",
        "Methylenedioxy-methamphetamine",
        "Phencyclidine",
        "Methadone",
        "2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP)",
        "Nortriptyline",
        "d-Propoxyphene"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Urine cup"
    ],
    "Instrument(s)/Platform(s)": [
        "Panel Dip Card",
        "Cup"
    ],
    "Method(s)/Technology(ies)": [
        "Competitive binding immunochromatographic assay",
        "Lateral flow"
    ],
    "Methodologies": [
        "Immunochromatographic assay",
        "Lateral flow"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for AssureTech Panel Dip Tests and Quick Cup Tests\u2014lateral flow immunochromatographic assay for qualitative multi-drug detection in urine",
    "Indications for Use Summary": "Qualitative, simultaneous detection of multiple drugs of abuse (including amphetamine, oxazepam, cocaine, marijuana, methamphetamine, morphine, oxycodone, secobarbital, buprenorphine, MDMA, phencyclidine, methadone, EDDP, nortriptyline, and d-propoxyphene) in human urine for in vitro diagnostic use; preliminary results require confirmation by more specific alternative chemical methods such as GC/MS or LC/MS.",
    "fda_folder": "Toxicology"
}